BUR in three months: buy, wait or sell?
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
- Buy / Wait / Sell rating
- 3-month target price
- Bear · Base · Bull
- vs. the market
What happened with BUR today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
Burford Capital supplies large businesses and law firms with funding for complex litigation and arbitration worldwide. It pays legal costs or gives clients cash upfront in exchange for rights to part of an expected recovery. When a claim succeeds, settlement payments, judgments or awards supply the money from which Burford recovers its investment and earns its agreed return. These investments, funded primarily with its own capital, generate most of its revenue. If a claim produces no proceeds or other value, Burford generally loses its investment.
It also manages legal-finance investments for outside investors, earning management fees, performance fees and agreed shares of investment profits. This is a secondary revenue source. A single sovereign wealth fund supplies a substantial share of the capital under management through BOF-C and a sidecar fund.
Cash receipts depend on cases resolving successfully and recoveries actually being collected, which can take years. The YPF-related Petersen and Eton Park claims represent a large share of Burford’s legal-finance asset value. Its financing arrangements must also comply with local rules that can restrict acquiring interests in claims or participating in lawyers’ fees; some arrangements may be unenforceable if they do not meet those requirements.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
Burford’s results hinge on litigation outcomes and when recoveries arrive, with particularly large exposure to claims arising from YPF’s expropriation and enforcement against Argentina.
Acacia Research Corporation shares Burford’s exposure to whether legal claims succeed and when they pay out, but its overlap is limited to intellectual property: Acacia buys and enforces patent rights to earn fees from licensees, while Burford funds businesses and law firms for a share of successful claims. Acacia’s patent-licensing revenue offers a narrower view of the legal recoveries that drive Burford’s returns.
Burford Capital Limited earningsThis company
Burford Capital advances money for companies’ and law firms’ legal costs in return for a share of successful recoveries; its report shows how case proceeds translate into investment income and cash.
Read capital-provision income alongside cash receipts from cases: income mainly reflects fair-value changes in assets, while receipts are cash actually collected. If both strengthen, more of the reported return is being backed by cash; if income and receipts both weaken, case outcomes or payment timing are still holding back realized returns.
Acacia Research Corporation earningsACTG
Acacia Research Corporation buys and enforces patent rights to collect fees from licensees; its report shows how payments in this narrow legal-claims market are flowing, a limited read on the recovery environment around Burford Capital.
Watch whether patent-licensing revenue grows and whether cash collections keep pace. Strength in both says some patent claims are turning into payments, a limited positive read-through for Burford Capital’s recovery-dependent model; weakness in both says collections in this niche are fading, but does not establish how Burford’s cases are resolving.